 | |
Cancer Research Institute
Awards Dinner
|
|
|
Keynote speaker Dr. Jedd D. Wolchok, CRI Advisory Council member Dr. Philip D. Greenberg, CRI Board co-chair Donald J. Gogel, CRI executive director Dr. Jill O'Donnell-Tormey, honoree Carlos A. Ferrer, honoree Dr. Michael J. Bevan, CRI Board co-chair Andrew M. Paul.
|
On
June 17, the Cancer Research Institute (CRI) hosted
its 22nd Annual Awards Dinner at The Rainbow Room
in New York City. More than 180 guests attended, raising $756,000
for the Institute’s research programs. CRI executive
director Jill O’Donnell-Tormey, Ph.D., emceed
the black-tie dinner, which honored philanthropic and corporate leaders
and scientists who have made significant contributions to the fight
against cancer. Cancer Research Institute co-chairman of the
board Donald J. Gogel, president & CEO of Clayton
Dubilier & Rice, spoke on behalf of the Institute, highlighting
its highly effective research programs, its efficient stewardship
of donor funds and public trust, and its unique model of international
collaboration and shared resources leveraging.
Keynote speaker Jedd D. Wolchok, M.D., director
of immunotherapy clinical trials at Memorial Sloan-Kettering Cancer
Center, shared his personal story of how he as a young research scientist
first became interested in tumor immunology. He credited Cancer
Research Institute Scientific Advisory Council Director Lloyd J.
Old, M.D., MSKCC investigator Alan Houghton, M.D., and the Cancer
Research Institute with opening many career-defining opportunities
for him in the field of tumor immunology. Dr. Wolchok told
how his work with melanoma patients over the years fueled his passion
to develop immune-based therapies to help them. Last year,
the USDA approved his DNA vaccine for the treatment of malignant
melanoma in dogs, making it the first approved therapeutic cancer
vaccine to be made commercially available. His vaccine is now
in trials with human patients with melanoma and other cancers.
The Institute feted two outstanding honorees whose contributions
to cancer research—either through philanthropy and leadership
or through scientific achievement—have made a significant impact
in the Institute’s efforts to advance immunology to conquer
cancer: Carlos A. Ferrer, who received the Oliver
R. Grace Award for Distinguished Service in Advancing Cancer
Research and Michael J.
Bevan, Ph.D., investigator, Howard Hughes Medical
Institute and professor of immunology at the University of
Washington, who received the William B. Coley Award
for Distinguished Research in Basic and Tumor Immunology.
The
Institute extends its gratitude to dinner co-chairs Peter
J. Crowley, managing director, global head of healthcare
investment, Oppenheimer & Co.; William M. Lewis Jr.,
co-chairman, investment banking, Lazard Ltd.; Wade F.B.
Thompson, chairman, president, and CEO, Thor Industries,
Inc.; and CRI co-chairmen of the Board of Trustees Donald
J. Gogel and Andrew M. Paul.
The Cancer Research Institute (CRI) is the world’s
only non-profit organization dedicated exclusively to the support
and coordination of scientific and clinical efforts that will lead
to the immunological treatment, control, and prevention of cancer.
Guided by a world-renowned Scientific Advisory Council that includes
five Nobel Prize winners and thirty members of the National Academy
of Sciences, CRI supports the finest cutting-edge cancer research
at top medical centers and universities throughout the world. As
the initiator and steward of unprecedented global laboratory and
clinical collaborations, the Cancer Research Institute is ushering
in a new era of scientific progress, hastening the discovery of effective
cancer vaccines and other immune-based therapies that are providing
new hope to cancer patients. The Cancer Research Institute has one
of the lowest overhead expense ratios among non-profit organizations,
with the majority of its resources going directly to the support
of its science, medical, and research programs. This has consistently
earned CRI an A grade or higher for fiscal disclosure and efficiency
from the American Institute of Philanthropy and top marks from other
charity watchdog organizations.www.cancerresearch.org.
|
Don Gogel, Georgia Wall, Jill O'Donnell-Tormey, Ed McDermott.
|
Matt, William, Annie, Rosemary & Carlos & Steve Ferrer.
|
Jedd Wolchok, Elaine and Harold Wolchok, Karen Popkin Wolchok.
|
Dr. Philip D. Greenberg and Dr. Michael J. Bevan.
|
Jill O'Donnell-Tormey, Gala co-chair Wade Thompson, Angela Thompson, Jennifer McCormick.
|
Jamie Kempner and Ann Croll.
|
|
Leslie Brille, David Lubin.
|
Michael and Shasha Targoff, Tom and Andrea Mendell, Jack Spadden.
|
The McGrath Family.
|
Andreina and Ed Mailhot.
|
|
Jim and Bronwen Kelly.
|
Cassie and Tom Clayton.
|
|
Mark and Barbara Leswing, Daniela and Ted Lundberg.
|
Lynne Harmer, CRI director of Communications Brian Brewer, Kelsey Fowler.
|
Leigh McDermott, Abby Smith, Ed McDermott.
|
Leigh Abrams, Greg Curt, Fred Zinn.
|
Jim Allison, Victoria and Andrew Simpson.
|
Tricia Summers and Justin Yang.
|
|
Kyle Pasewark, Vivian Blanco, Laura Sullivan.
|
Bob and Yumiko, Harry and Ariel Posner.
|
Carlos Ferrer, Justin Yang, Ryan Kirkpatrick, Peer Pederson, Tom Clayton.
|
David Freeman, Cathy and John Weiland.
|
Virginia, Lorraine and Oliver Grace, Tom Seifert, Mark Leswing.
|
Glenn and Ginger DeSimone.
|
|
Carlos Ferrer, Margaret and Andy Paul.
|
David and Cindy Auth.
|
|
Kate McKenzie, Kirsten Evraire.
|
Joari DeMiranda, Joanna Barata, Yu-chin Lo.
|
Rob Gaynor, Todd Richter, Andrea Renalde, Brian Brille, Bob Dahl.
|
Abby Smith and Frederick Johnston.
|
|
Jamie Kempner and Peter Crowley.
|
Rindy and Rosh Dias and Francois diTrapani.
|
| Photos:
Elaine Ubiña |
